TRPV2 and TRPM2 channels facilitate pulmonary endothelial barrier recovery after ROS-induced permeability

TRPV2 and TRPM2 channels facilitate pulmonary endothelial barrier recovery after ROS-induced permeability | bioRxiv /* */ /* */ <!-- <!-- /*! * yepnope1.5.4 * (c) WTFPL, GPLv2 */ (function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548'); Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results TRPV2 and TRPM2 channels facilitate pulmonary endothelial barrier recovery after ROS-induced permeability Lena Schaller , Thomas Gudermann , View ORCID Profile Alexander Dietrich doi: https://doi.org/10.1101/2025.02.13.638083 Lena Schaller 1 Walther Straub Institute for Pharmacology and Toxicology, Member of the German Center for Lung Research (DZL), School of Medicine, LM University of Munich , Nußbaumstrasse 26, 80336 Munich, Germany Find this author on Google Scholar Find this author on PubMed Search for this author on this site Thomas Gudermann 1 Walther Straub Institute for Pharmacology and Toxicology, Member of the German Center for Lung Research (DZL), School of Medicine, LM University of Munich , Nußbaumstrasse 26, 80336 Munich, Germany Find this author on Google Scholar Find this author on PubMed Search for this author on this site Alexander Dietrich 1 Walther Straub Institute for Pharmacology and Toxicology, Member of the German Center for Lung Research (DZL), School of Medicine, LM University of Munich , Nußbaumstrasse 26, 80336 Munich, Germany Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Alexander Dietrich For correspondence: alexander.dietrich{at}lrz.uni-muenchen.de Abstract Full Text Info/History Metrics Preview PDF ABSTRACT Reactive oxygen species (ROS), such as hydrogen peroxide (H 2 O 2 ), are known signaling molecules that increase endothelial barrier permeability. In this study, we investigated the roles of two redox-sensitive transient receptor potential (TRP) ion channels, TRPM2 and TRPV2, in H 2 O 2 - induced endothelial barrier dysfunction. Using primary human pulmonary microvascular endothelial cells (HPMEC), we employed impedance-based resistance measurements, Western blot, and immunofluorescence staining to assess the effects of H 2 O 2 on the endothelial barrier. Exposure to sublytic concentrations of H 2 O 2 caused an acute loss of endothelial barrier integrity, accompanied by the cleavage of vascular endothelial cadherin (VE-cadherin), which was also apparent after application of the TRPV2 activator cannabidiol. The inhibition of either TRPV2 with tranilast or a disintegrin and metalloprotease domain-containing protein 10 (ADAM10) with GI254023X significantly reduced H 2 O 2 -induced VE-cadherin cleavage, while TRPM2 inhibition by econazole significantly increased H 2 O 2 -driven VE-cadherin cleavage. Although inhibition of either TRP channel did not prevent the initial loss of barrier resistance upon H 2 O 2 exposure, both were essential for the subsequent recovery of barrier integrity. Time-course immunofluorescence stainings revealed that HPMEC barrier recovery involved a transient localization of N-cadherin proteins at cell-cell junctions, which were replaced by VE-cadherin within 90 minutes. This process of cadherin-switching did not occur upon inhibition of TRPV2 or ADAM10. Our results highlight complementary roles for TRPM2 and TRPV2 as redox sensitive ion channels in the microvascular endothelium and provide insight into the mechanisms underlying pulmonary microvascular endothelial barrier recovery. Download figure Open in new tab 1. Introduction The barrier formed by the pulmonary microvasculature is constitutively restrictive, preventing both pathogen infiltration and edema formation while facilitating the exchange of gases and nutrients between the bloodstream and surrounding tissue [ 1 , 2 ]. While a transient increase in permeability supports biological functions such as wound repair, angiogenesis and immune cell trafficking [ 3 , 4 ], prolonged or extensive permeability can result in pulmonary edema, acute respiratory distress syndrome (ARDS) [ 5 ] and atherosclerosis [ 6 ]. Reactive oxygen species (ROS), such as hydrogen peroxide (H 2 O 2 ), are known effectors of altered endothelial barrier function [ 7 – 10 ]. ROS can arise from exogenous triggers, including infection, ionizing radiation or toxicants, but also occur naturally in the body, such as during mitochondrial respiration [ 11 , 12 ]. The concept of an “oxidative window” describes the optimal range of ROS levels that facilitate cellular processes such as neovascularization, cell proliferation and wound healing [ 7 , 8 , 13 ]. Deviations from this balance, resulting in oxidative or reductive stress, lead to cellular dysfunction [ 8 ]. Adherens junctions (AJs), comprised of Ca 2+ -dependent, homotypic adhesions between the vascular endothelial cadherin (VE-cadherin) proteins of neighboring cells, are essential components of the endothelial barrier [ 3 , 14 ]. While the formation of AJs depends on extracellular Ca 2+ , an increase in intracellular Ca 2+ can induce endothelial barrier permeability [ 3 , 15 ]. Members of the Transient Receptor Potential (TRP) superfamily form nonselective cation channels that conduct Ca 2+ , and several TRP channels have been implicated in Ca 2+ -induced barrier dysfunction [ 3 ]. It has been reported that TRP-induced Ca 2+ influx could activate a disintegrin and metalloprotease domain-containing protein 10 (ADAM10) [ 16 ], a metalloprotease known to cleave VE-cadherin at its extracellular domain [ 17 ]. However, a ROS-driven, ADAM10-mediated cleavage of VE-cadherin has yet to be reported in pulmonary microvascular endothelial cells. TRPM2 is a recognized mediator of ROS-induced Ca 2+ influx. Expressed in the brain, immune cells, and vasculature, TRPM2 forms a tetrameric, nonselective ion channel that conducts Ca 2+ and is gated by adenosine diphosphate ribose (ADPR) [ 18 – 21 ], which is generated as a result of ROS-induced DNA damage [ 18 , 19 ]. While TRPM2 is a known modulator of pulmonary endothelial barrier permeability, its knockdown does not completely abolish endothelial Ca 2+ influx following ROS exposure, suggesting the involvement of additional redox sensitive Ca 2+ channels [ 9 , 22 ]. The second member of the vanilloid TRP subfamily, TRPV2, is a potential candidate for the undefined source of ROS-induced pulmonary endothelial Ca 2+ influx. Originally associated with mechanoreception [ 23 ], TRPV2 also operates as a redox-sensitive ion channel [ 24 , 25 ], and is highly expressed in the microvascular endothelium in relation to other redox sensitive TRP channels, including TRPM2 and TRPV4 [ 26 ]. While TRPV2 has been linked to changes in blood-brain barrier integrity [ 27 ], there is no evidence to date linking the channel to altered pulmonary microvascular endothelial barrier function [ 28 ]. Here, we applied pharmacological inhibitors to investigate the role of TRPM2 and TRPV2 in H 2 O 2 -induced pulmonary endothelial barrier dysfunction. Neither channel was responsible for the initial loss of barrier resistance, but both channels facilitated the subsequent recovery of barrier integrity. In this model, TRPV2 mediated AJ integrity by inducing ADAM10-driven VE-cadherin cleavage, which was further increased upon TRPM2 inhibition. Endothelial barrier recovery was characterized by the translocation of neural cadherin (N-cadherin) to the plasma membrane upon VE-cadherin removal, suggesting a role for TRP-mediated cadherin switching in the restoration of endothelial barrier function following ROS-induced permeability. 2. Methods Cells Primary human pulmonary microvascular endothelial cells (HPMECs) [ 29 ] from healthy donors were obtained from Promocell (Heidelberg, Germany, #C-12281) and cultured in endothelial cell growth medium MV (Promocell, #C-22020) at 37 °C and 5 % CO 2 , and were kept until passage 12. Donor information is provided in Supp. Table S1 . Relevant ethical statements were provided by Promocell. For experiments involving pharmacological inhibition, HPMECs were pre-incubated for 1 hr in DMEM containing the respective inhibitor(s), which were also present during the subsequent exposure period. Quantification of endothelial barrier resistance HPMECs were seeded onto electrical cell-substrate impedance sensing (ECIS) plates at a density of 8 x 10 4 cells/well (Applied Biophysics, Troy, NY, USA, 8W10E+), which had been treated with 10 mM of L-Cysteine according to the manufacturer’s recommendation. HPMEC barrier resistance was measured at 4000 Hz using the ECIS ZΦ device (Applied Biophysics), and experiments were conducted once the monolayer resistance had reached a constant state (after ∼48 hr). 3. Results 3.1. H 2 O 2 exposure at non-cytolytic concentrations increases HPMEC barrier permeability and triggers ADAM10-dependent VE-cadherin cleavage Using H 2 O 2 to mimic ROS production in response to infection, radiation or other toxicants, we monitored changes in barrier resistance of human pulmonary microvascular endothelial cells (HPMEC). While H 2 O 2 exposure did not exert detectable cytolytic effects after 2 hours ( Supp. Fig. S1 ), changes in HPMEC barrier resistance were observed within 5 minutes of exposure ( Fig. 1A ). 15 minutes post H 2 O 2 addition (40 minutes after starting the experiment in Fig 1A ), mean HPMEC barrier resistance dropped to 45% ± 11% and 47% ± 14% of the control in cells treated with 75 μM and 300 μM H 2 O 2 , respectively, with recovery noted only in HPMECs treated with 75 μM H 2 O 2 ( Fig. 1B ). Additionally, Western blot analysis revealed that H 2 O 2 exposure caused the formation of a single ∼35 kDa VE-cadherin C-terminal fragment (CTF) ( Supp. Fig. S1B, C ), the formation of which was prevented by the addition of the specific ADAM10 inhibitor GI254023X [ 30 ] (GI254, see Supp. Table S2 for IC 50 values) ( Fig. 1C, D ). ADAM10-dependent regulation of VE-cadherin was also observed in immunofluorescence stainings, which showed that ADAM10 inhibition reduced the loss of VE-cadherin signal at cell-cell junctions after H 2 O 2 exposure ( Fig. 1E and F ). Download figure Open in new tab Fig. 1: H 2 O 2 induces HPMEC barrier instability and ADAM10-dependent VE-cadherin cleavage. Changes in HPMEC electrical resistance (normalized to baseline levels) were recorded with an ECIS device at 4000 Hz upon application of H 2 O 2 (75 µM, 300 µM) ( A ). The normalized resistance values 15 and 90 min after exposure were quantified ( B ). Representative Western blot (from one donor, 3 technical replicates) of the full length (FL) and C-terminal fragment (CTF) levels of VE-cadherin protein in HPMECs 2 h after H 2 O 2 exposure (300 µM) in the presence and absence of the ADAM10 inhibitor GI254023X (GI254, 3 μM) ( C ). β-actin was probed as a loading control. Normalized levels of VE-Cadherin CTF from these Western blots were quantified ( D ). ( E ) Immunofluorescence staining of HPMECs using a VE-cadherin antibody (green) and DAPI (blue), scale bar: 50 µm. Cells were fixed 2 h after H 2 O 2 exposure in the presence and absence of GI254 (3 μM). ( F ) Fluorescence intensity profiles (measured along the dashed white lines in ( E )) of VE-cadherin and DAPI signal. Data reflect the mean ( A , B , D ) + SD ( B , D ) from 3 independent donors ( n = 3). Significance between means was analyzed using two-way ANOVA and Tukey post hoc tests ( B , D ); ** p < 0.01, *** p < 0.001, **** p < 0.0001. 3.2 TRPV2 mediates ADAM10-driven VE-cadherin shedding upon H 2 O 2 exposure We next sought to determine the involvement of the redox-sensitive TRP channels, TRPV2 and TRPM2, in H 2 O 2 -induced HPMEC barrier dysfunction. Quantitative rt-PCR confirmed that both genes were transcribed in HPMECs ( Supp. Fig. S2A ), and both proteins were detected in cell lysates via Western blot ( Supp. Fig. S2B, C ). Ca 2+ imaging experiments revealed that the increase of intracellular Ca 2+ ([Ca 2+ ] i ) upon H 2 O 2 exposure was dependent on both channels ( Supp. Fig S2D, E ). At the protein level, pre- and co-incubation with the TRPV2 inhibitor tranilast [ 31 ] significantly reduced the H 2 O 2 -driven, ADAM10-mediated cleavage of VE-cadherin ( Fig. 2A ) when quantified ( Fig. 2B ). The TRPV2/ADAM10 VE-cadherin cleavage pathway was further confirmed with the TRPV2 activator, cannabidiol (CBD) [ 27 ] ( Fig. 2C , quantified in D). Conversely, inhibition of TRPM2 with econazole [ 32 ] increased the formation of the H 2 O 2 -driven VE-cadherin cleavage product ( Fig. 2E , quantified in F). These results were corroborated using alternate TRPV2 and TRPM2 inhibitors ( Supp. Fig. S3A-D ). Notably, while gene transcripts of the redox-sensitive TRPV4 channel were also detected in HPMECs ( Supp. Fig. S2A ), pretreatment with the specific TRPV4 inhibitor GSK2193874 [ 33 ] had no effect on the degree of H 2 O 2 –induced VE-cadherin CTF formation ( Supp. Fig. S3E, F ). Download figure Open in new tab Fig. 2: TRPV2 and TRPM2 VE-cadherin cleavage in HPMECs. Representative Western blot (from one donor, 3 technical replicates) of FL and CTF VE-cadherin protein levels in HPMECs upon TRPV2 inhibition (50 µM tranilast) and 2 h exposure to H 2 O 2 (300 µM; A , quantified in B ). ( C ) Representative Western blot (from one donor, 3 technical replicates) of FL and CTF VE-cadherin protein levels in HPMECs upon ADAM10 inhibition (3 µM GI254023X, GI254) and 2 h exposure to cannabidiol (CBD, 50 µM), quantified in ( D ). Representative Western blots (from one donor, 3 technical replicates) of FL and CTF VE-cadherin protein levels in HPMECs upon TRPM2 inhibition (10 µM econazole) and 2 h exposure to H 2 O 2 (300 µM; E , quantified in F ). β-actin was probed as a loading control. Quantified data ( B , D, F ) reflect the mean + SD from 3 independent donors ( n = 3). Significance between means was analyzed using two-way ANOVA, with Tukey post hoc tests; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. 3.3. Recovery of HPMEC barrier integrity requires TRPV2 and TRPM2 functionality We next assessed whether inhibition of TRPV2 and TRPM2 channels would influence the HPMEC barrier response to H 2 O 2 . The protective effect of TRPM2 on VE-cadherin cleavage was also evident in our measurements of barrier resistance, as application of the TRPM2 inhibitor econazole prior to the addition of 75 μM H 2 O 2 significantly impaired HPMEC barrier recovery ( Fig. 3A ), with resistance values dropping to 33% ± 23% of control values after 90 minutes of treatment ( Fig. 3B ). In addition to TRPM2, TRPV2 activity was also necessary for HPMEC barrier recovery. HPMECs exposed to 75 μM H 2 O 2 experienced significantly reduced recovery when pretreated with tranilast ( Fig. 3C , quantified in Fig. 3D ). Download figure Open in new tab Fig. 3: TRPM2 and TRPV2 facilitate HPMEC barrier recovery following H 2 O 2 exposure. Changes in barrier resistance (normalized to baseline) were measured in HPMECs which were preincubated with DMSO or econazole (econ, 10 µM, 1 h) and subsequently exposed to 75 µM H 2 O 2 ( A ). HPMEC resistance values (presented as % of control values) were quantified 15 and 90 min after H 2 O 2 application (B) Similar experiments were conducted with the TRPV2 inhibitor tranilast (tran, 50 µM, 1 h preincubation, ( C, D )). Data represent mean ( A - D ) + SD ( B , D ) of results from 3 independent donors ( n = 3), and significance between means was analyzed with two-way ANOVA and Tukey post hoc tests; * p < 0.05, ** p < 0.01. 3.4. TRPV2 facilitates HPMEC barrier recovery through “cadherin switching” TRPV2-driven VE-cadherin cleavage could facilitate HPMEC barrier recovery by enabling the translocation of neural cadherin (N-cadherin) to the plasma membrane, promoting wound healing. A time-course series of immunofluorescence stainings revealed that, upon exposure to 75 μM H 2 O 2 , VE-cadherin was rapidly removed from the cell surface after 15 minutes, but reappeared within 90 minutes ( Fig. 4A ). In contrast, N-cadherin, while initially dispersed in the intracellular space, organized at the plasma membrane 15 minutes after H 2 O 2 exposure, returning to the intracellular space within 90 minutes ( Fig. 4B ). An analysis of fluorescence intensity profiles drawn between adjacent HPMECs (see Supp. Fig. 4A, B ) confirmed that both the transient loss of VE-cadherin and the increase in N-cadherin signal at the cell borders 15 minutes after H 2 O 2 exposure were significantly reduced upon either TRPV2 or ADAM10 inhibition ( Fig. 4C, D ). In HPMECs pretreated with the TRPM2 inhibitor econazole, VE-cadherin was also lost from the plasma membrane upon H 2 O 2 application, concurrent with N-cadherin recruitment. However, VE- cadherin signal remained absent from the plasma membrane even at 90 minutes post-exposure ( Supp. Fig. S4C-F ). Download figure Open in new tab Fig. 4: TRPV2 and ADAM10 are necessary for altered localization of N- and VE-cadherin following H 2 O 2 exposure. ( A ) HPMEC immunofluorescence staining of VE-cadherin (red) over a timecourse of H 2 O 2 exposure (75 µM; 0 min, 15 min, 90 min) in the presence and absence of TRPV2 and ADAM10 inhibitors (50 µM tranilast, 3 µM GI254023X, respectively). Further immunofluorescence stainings for N-cadherin (green) were conducted in the same conditions ( B ). Nuclei were stained with DAPI (blue), scale bars: 50 µm. Mean peak signal intensities of VE-cadherin ( C ) and N-cadherin ( D ) from fluorescence intensity profiles were quantified from stainings performed in HPMECs from three different donors ( n = 3, 30 regions per n ), and significance between means was analyzed with two-way ANOVA and Tukey post hoc tests; * p < 0.05, ** p < 0.01, *** p < 0.001. 4. Discussion ROS are not only mediators of vascular pathology, but are also critical signaling molecules for endothelial cell proliferation, growth and motility [ 7 , 8 , 13 , 34 ]. In this study, we describe a pathway by which TRPV2 channels, alongside TRPM2 channels, modulate AJ protein composition and facilitate the recovery of HPMEC barrier function after H 2 O 2 exposure. We found that TRPV2, a redox-sensitive channel, played a significant role in mediating HPMEC response to ROS. H 2 O 2 exposure triggered an [Ca 2+ ] i increase within 5 minutes, a reaction which was significantly reduced upon pharmacological inhibition of TRPV2. During oxidative signaling, TRPV2 localizes at the cell podosome, a membrane region that supports cell motility through localized proteolysis [ 35 , 36 ]. Along this line, we observed that TRPV2 inhibition prevented the H 2 O 2 -driven cleavage of VE-cadherin, a known substrate of the Ca 2+ -activated protease ADAM10 [ 17 ]. Therefore, we propose a TRPV2/ADAM10/VE-cadherin pathway through which HPMECs respond to ROS via ectodomain cleavage of VE-cadherin. This cleavage event may not be restricted to ADAM10 and VE-cadherin, and the involvement of other Ca 2+ -activated proteases and their cell-adhesion substrates presents a promising avenue for further study. In addition, it remains to be determined whether the extracellular fragment of VE-cadherin released during this process plays a role in downstream signaling, as is the case with its epithelial counterpart E-cadherin [ 37 ]. Our study also offers insight into the complex function of TRPM2 in mediating vascular permeability. We observed that the H 2 O 2 -driven [Ca 2+ ] i increase in HPMECs was significantly reduced upon pharmacological inhibition of TRPM2. These findings corroborate those of Mittal et al. , who also described a TRPM2-dependent increase in VE-cadherin phosphorylation at sites necessary for the protein’s internalization [ 22 , 38 ]. VE-cadherin internalization, which occurs upon H 2 O 2 exposure [ 39 ], is an early step in cell migration [ 40 ] and could have significant implications for wound healing following vascular injury. We found that the return of VE-cadherin signal at the plasma membrane and recovery of monolayer integrity following H 2 O 2 exposure were only possible with TRPM2 functionality. It is possible that, where TRPV2 activation promotes localized VE-cadherin proteolysis at the podosome, TRPM2 could facilitate temporary internalization of full-length VE-cadherin proteins until the barrier can be reestablished. This role for TRPM2 would also account for the increase in H 2 O 2 -induced VE-cadherin CTF formation upon TRPM2 inhibition. In confluent endothelial cells, VE-cadherin localizes primarily to AJs at the plasma membrane, where it is thought to contribute to contact inhibition of cell growth and proliferation [ 41 , 42 ]. N-cadherin, in contrast, is associated with cell migration and wound healing and is unable to translocate to the plasma membrane in the presence of VE-cadherin at AJs [ 41 , 43 ]. With VE- cadherin removed from the plasma membrane, N-cadherin translocates to the cell surface, where it can form heterotypic adhesions with neighboring cells. The resulting N-cadherin adhesion complex promotes Rac1 activation, which in turn induces the recruitment of VE-cadherin back to AJs [ 44 ]. We were able to clearly observe this mechanism of cadherin-switching in our immunofluorescence stainings, which could also explain why the inhibition of the TRPV2/ADAM10/VE-cadherin cleavage pathway was detrimental to the recovery of HPMEC barrier resistance following H 2 O 2 exposure. Our results support a pathway by which redox-sensitive TRPV2 channels facilitate the removal of VE-cadherin from HPMEC AJs through ectodomain cleavage. The resulting paracellular gaps are then rapidly repaired, possibly through N-cadherin-mediated recruitment of VE-cadherin. This pathway could be particularly relevant during leukocyte transmigration, which is characterized by H 2 O 2 release [ 45 ], a temporary increase in paracellular permeability and a focal, transient loss of VE-cadherin complexes at AJs [ 4 ]. Funding This study was supported by grants from the Deutsche Forschungsgemeinschaft (TRR152, (TG, AD) and GRK 2338 (LS, TG, AD), Deutsches Zentrum für Lungenforschung (DZL) (TG, AD). CRediT authorship contributions statement Lena Schaller: Conceptualization, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing - review & editing. Thomas Gudermann : Project administration, Writing – review & editing. Alexander Dietrich : Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Visualization, Writing – review & editing Declaration of competing interests The authors have no conflict of interest to declare. Data availability All data are available in the main text or the supplementary materials. Sppendix A. upplementary data Supplementary data to this article will be found online. Supplementary Methods Reagents and Antibodies The following reagents and antibodies were used: High glucose Dulbecco’s Modified Eagle Medium (DMEM, Thermo Fisher Scientific, Waltham, US, #41965039); hydrogen peroxide solution (Merck, Darmstadt, Germany, H1009); GI254023X (Tocris, Bristol, UK, #3995); econazole (Merck, Y0001236); JNJ-28583113 (MedChemExpress, Monmouth Junction, US, #HY-149143); tranilast (Tocris, #1098); valdecoxib (Merck, #PZ0179); cannabidiol (Cayman Chemical, #90080, Ann Arbor, MI, USA); GSK2193874 (Tocris, #5106); anti-VE-Cadherin antibody (Cell Signaling, Danvers, US, #2500); anti-N- Cadherin antibody (Cell Signaling, #13116); horseradish peroxidase (HRP)-conjugated anti-β-actin antibody (Merck, #A3854); anti-TRPM2 antibody (Bethyl, Montgomery, Texas, USA, A300-414A); anti-TRPV2 antibody (Abcam, Cambridge, UK, Ab272862); peroxidase (POX)-conjugated anti-rabbit antibody (Merck, #A1654); goat anti-rabbit IgG Alexa Fluor 488 (Thermo Fisher Scientific, #A-11008). See complete antibody information in Supp. Table S3 . SDS-PAGE and western blot analysis The expression of VE-cadherin protein was evaluated by Western blot analysis as previously described ( 60 ). Following treatment, HPMECs were lysed in 150 ul RIPA buffer (with protease and phosphatase inhibitors) for 30 min on ice. Protein concentration was quantified with the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, #23225) according to the manufacturer’s protocol. Protein samples (10 µg lysate, 1x Laemmli buffer (prepared from 5x stock: 3 ml TRIS/HCl (2.6 M), pH 6.8; 10 ml glycerin; 2 g SDS; 2 mg bromophenol blue; 5 ml β-mercaptoethanol)) were heated for 10 min at 95 °C and loaded onto an SDS-PAGE gel (4 % stacking, 10 % separating). SDS-PAGE gel electrophoresis was run for 30 min at 80 V, and then at 120 V for 90 min. Proteins were then transferred from the gel to a Roti®-PVDF membrane (Roth, Karlsruhe, Germany, #T830.1) in a wet transfer system (BioRad, Feldkirchen, Germany) at 50-60 V for 1.5 h. The membrane was then blocked with 5 % low-fat milk (Roth, #T145.2) in TBS-T (0.1 % Tween20) for 1 h at RT. All antibodies were diluted in the milk blocking solution. See Supp. Table S3 for relevant antibody information. Membranes were incubated in the primary antibody solutions overnight at 4 °C. Afterwards, membranes were washed (3 x 10 min, TBS-T) and incubated for 2 h at RT in peroxidase-conjugated secondary antibody solutions. Chemiluminescence was detected following incubation in SuperSignal West Femto or Pico maximum sensitivity substrates (Life Technologies, CA, USA, #34095 and #34580), using an Odyssey-Fc unit (Licor, Lincoln, NE, USA). Full, uncut Western blots for all experiments, donors and replicates can be accessed at https://osf.io/4uy8s/?view_only=a6c92c575798494c9c634e230bcbbb65 . Immunocytochemistry HPMECs were seeded on poly-L-lysine-coated 12 mm glass coverslips. After treatment, cells were washed once with cold PBS, fixed in 4 % PFA/PBS (15 min, RT), and then washed thrice with cold PBS. Cells were permeabilized for 10 min at RT in a 0.2 % Triton X-100/PBS solution, and then washed 4 x 5 min in PBS-T (0.1 % Tween20 in PBS). HPMECs were blocked for 1 h in PBS with 0.1 % Tween20 and 5 % BSA, and then incubated overnight at 4 °C in primary antibody solutions prepared in blocking buffer. See complete antibody information in Supp. Table S3 . The following day, cells were washed (4 x 5 min, PBS-T), incubated for 2 h at RT in secondary antibody solutions, and washed again (4 x 5 min, PBS-T). All antibodies were diluted in blocking buffer. Nuclei were stained with DAPI (0.1 mg/l in PBS) for 3 min at RT, after which cells were washed (4 x 5 min, PBS-T). Coverslips were mounted with PermaFluor mounting medium (Epredia, Kalamazoo, MI, USA, #TA-030-FM) and kept at 4 °C. Confocal images were taken with a Zeiss LSM 880 microscope (Zeiss, Oberkochen, Germany) using the ZEN Black software (Zeiss, version 2.3). Images were processed with FIJI software (Image J v.1.53c, Wayne Rasband, NIH, USA) ( 61 ). Fluorescence intensity profiles were drawn in ZEN Blue software (Zeiss, version 3.4). For signal quantification, profiles were drawn between the nuclei of two adjacent HPMECs. Mean peak intensity values from ten profiles were calculated for 3 images from each condition, and these experiments were replicated thrice in different donors. Statistical analysis Statistical analysis was performed with GraphPad Prism 10 software (GraphPad Software, San Diego, USA). Significant differences are indicated by asterisks, where p < 0.05 (*), 0.01 (**), 0.001 (***), and 0.0001 (****). LDH Cytotoxicity Assay H 2 O 2 -induced cytotoxicity was assessed through an LDH assay (Merck, #11644793001), according to the manufacturer’s protocol. Briefly, cells were incubated in 300 µM H 2 O 2 for 2h, at which point the supernatant was collected and tested for the reduction of tetrazolium salt by NADH as a measure of LDH activity. Triton X100 (2%) was applied as a positive control. Quantitative Reverse-Transcription (qRT)-PCR Total RNA from HPMECs was isolated with the RNeasy Plus Mini Kit (Qiagen, Hilden, Germany, #74136). 1 µg mRNA was then transcribed to cDNA using the RevertAid H Minus First Strand cDNA Synthesis Kit (Life Technologies, Darmstadt, Germany, #K1631), with reverse transcription polymerase and random primers according to the manufacturer’s protocol. The levels of mRNA transcripts of target genes were assessed using real-time quantitative PCR, as described previously ( 60 ). Briefly, 3 µl of template cDNA was added to 7 µl of a master mix containing 2x Absolute QPCR SYBR Green Mix (Life Technologies, #AB1158B), 10 pmol of the respective primer pair (Metabion, Planegg, Germany, see table S4 for primer sequences) and water. For qRT-PCR, the following program was run in a light-cycler 480 device (Roche, Mannheim, Germany): activation (15 min, 94 °C); 45 cycles of denaturation (12 s, 94 °C), annealing (30 s, 50 °C) and extension (30 s, 72 °C); and melting curve analysis. The default lightcycler software (Roche, Basel, Switzerland) allowed for the calculation of crossing points (Cps), which were used to calculate gene expression values. Ca 2+ imaging HPMECs were grown on poly-L-lysine-coated 24 mm glass coverslips until 80 % confluency. On the day of measurement, HPMECs were loaded with 2 µM Fura-2-AM (Merck, #47989-1MG-F) in Ca 2+ buffer (0.1 % BSA in HBSS (with Ca 2+ , Mg 2+ and 0.5 M HEPES)) for 25 min at 37 °C. Coverslips were then washed with HEPES/HBSS buffer, placed into a quick-change chamber (Warner instruments, Holliston, USA, #64-0367) with 450 uL HEPES/HBSS, and positioned on the 40x oil-objective of a Leica DM98 fluorescence microscope. Changes in intracellular Ca 2+ concentration following the application of H 2 O 2 (300 μM, Merck, #H1009) were recorded at 340 and 380 nm wavelengths, as described ( 60 ). For measurements involving pharmacological inhibition, the respective inhibitors were included in both the Fura incubation solution and the treatment solutions. Supplementary Figure Legends Download figure Open in new tab Fig. S1. Non-cytolytic concentrations of H 2 O 2 cause VE-cadherin degradation. ( A ) Degree of cytolysis, measured in terms of lactate dehydrogenase (LDH) activity, in HPMECs after 2 h H 2 O 2 exposure (300 µM). Data represent the mean + SD of results from 3 independent donors ( n = 3). Significance was assessed using a paired t test. ( B ) Western blot of the full length (FL) and C-terminal fragment (CTF) levels of VE-cadherin protein in HPMECs 2 h after H 2 O 2 exposure at varying concentrations (75 µM, 150 µM and 300 µM). β-actin was probed as a loading control. Normalized levels of VE-Cadherin CTF from these Western blots were quantified ( C ). Data represent 3 technical replicates from one donor ( n = 1). ns = no significance. Download figure Open in new tab Fig. S2. TRPM2 and TRPV2 mediate H 2 O 2 -induced Ca 2+ influx in HPMECs. ( A ) TRP gene expression results, as detected by qRT-PCR, normalized to β-actin. Data reflect mean values + SD from 3 independent donors ( n = 3). TRPM2 ( B ) and TRPV2 ( C ) proteins were detected in HPMEC lysates by Western blot. ( D ) Mean ΔF/F 0 traces of HPMEC monolayer Ca 2+ influx following H 2 O 2 exposure (300 µM) in the presence and absence of the TRPM2 and TRPV2 inhibitors, econazole (10 µM) and tranilast (50 µM). Data represent the mean ± SD from one experiment, 35-50 cells/treatment group. This experiment was performed three times in HPMECs from a single donor at different passage numbers ( n = 3), and the area under the curve (AUC) of each mean ΔF/F 0 Ca 2+ trace was quantified ( E ), with bars reflecting the mean + SEM. Significance between means was analyzed using a one-way ANOVA, with Tukey post hoc test; * p < 0.05, ** p < 0.01, *** p < 0.001. Download figure Open in new tab Fig. S3. Additional controls for TRPM2 and TRPV2 modulation of HPMEC VE-cadherin upon H 2 O 2 exposure. Representative Western blots of FL and CTF VE-cadherin protein levels after H 2 O 2 exposure (2 h, 300 µM) upon TRPV2 ( A , quantified in B ), TRPM2 ( C , quantified in D ) and TRPV4 ( E , quantified in F ) inhibition (100 µM valdecoxib, 10 µM JNJ-28583113 and 300 nM GSK2193874, respectively). For all Western blots, β-actin was probed for as a loading control, samples shown are from a single donor, 3 technical replicates. Western blot quantifications represent the mean + SD of results from 3 independent donors ( B , D ) or 3 consecutive passages from one donor ( F ); ( n = 3). Significance between means was analyzed using two-way ANOVA, with Tukey post hoc test; * p < 0.05, ** p < 0.01. Download figure Open in new tab Figure S4. Representative fluorescence intensity profiles and immunofluorescence results for H 2 O 2 -induced changes in cadherin localization during TRP inhibition. Representative fluorescence intensity profiles (indicated by the thick white line in the image insets) for regions spanning HPMEC cell-cell junctions and adjacent nuclei in cells at 0 min ( A ) and 15 min ( B ) of H 2 O 2 exposure (75 µM). Scale bars: 50 µm. Timecourse immunofluorescence stainings of VE-cadherin (red) ( C ) and N-cadherin (green) ( D ) over a timecourse of H 2 O 2 exposure (75 µM; 0 min, 15 min, 90 min) in the presence and absence of the TRPM2 inhibitor econazole (10 µM). Nuclei were stained with DAPI (blue), scale bars: Mean peak signal intensities of VE-cadherin ( E ) and N-cadherin ( F ) from fluorescence intensity profiles were quantified from stainings performed in HPMECs from three different donors ( n = 3), and significance between means was analyzed with two-way ANOVA, and Tukey post hoc tests; * p < 0.05, ** p < 0.01. View this table: View inline View popup Download powerpoint Table S1: HPMEC donor information (Promocell) View this table: View inline View popup Download powerpoint Table S2: IC 50 values for TRP and ADAM inhibitors View this table: View inline View popup Download powerpoint Table S3: Antibodies used for Western blotting and immunocytochemistry View this table: View inline View popup Download powerpoint Table S4: DNA-sequences of qRT-PCR primer pairs Acknowledgments The authors would like to thank Bettina Braun and Benedikt Kirmayer for their excellent technical assistance. References and Notes 1. ↵ Simmons , S. ; Erfinanda , L. ; Bartz , C. ; Kuebler , W.M . Novel mechanisms regulating endothelial barrier function in the pulmonary microcirculation . J Physiol 2019 , 597 , 997 – 1021 , doi: 10.1113/jp276245 . OpenUrl CrossRef PubMed 2. ↵ Müller-Redetzky , H.C. ; Suttorp , N. ; Witzenrath , M . Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives . Cell Tissue Res 2014 , 355 , 657 – 673 , doi: 10.1007/s00441-014-1821-0 . OpenUrl CrossRef PubMed 3. ↵ Mehta , D. ; Malik , A.B . Signaling mechanisms regulating endothelial permeability . Physiol Rev 2006 , 86 , 279 – 367 , doi: 10.1152/physrev.00012.2005 . OpenUrl CrossRef PubMed Web of Science 4. ↵ Allport , J.R. ; Muller , W.A. ; Luscinskas , F.W . Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow . J Cell Biol 2000 , 148 , 203 – 216 , doi: 10.1083/jcb.148.1.203 . OpenUrl Abstract / FREE Full Text 5. ↵ Wang , C.Y. ; Calfee , C.S. ; Paul , D.W. ; Janz , D.R. ; May , A.K. ; Zhuo , H. ; Bernard , G.R. ; Matthay , M.A. ; Ware , L.B. ; Kangelaris , K.N . One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome . Intensive Care Med 2014 , 40 , 388 – 396 , doi: 10.1007/s00134-013-3186-3 . OpenUrl CrossRef PubMed Web of Science 6. ↵ Theofilis , P. ; Sagris , M. ; Oikonomou , E. ; Antonopoulos , A.S. ; Siasos , G. ; Tsioufis , C. ; Tousoulis , D . Inflammatory Mechanisms Contributing to Endothelial Dysfunction . Biomedicines 2021 , 9 , doi: 10.3390/biomedicines9070781 . OpenUrl CrossRef PubMed 7. ↵ Fukai , T. ; Ushio-Fukai , M . Cross-Talk between NADPH Oxidase and Mitochondria: Role in ROS Signaling and Angiogenesis . Cells 2020 , 9 , doi: 10.3390/cells9081849 . OpenUrl CrossRef 8. ↵ Urao , N. ; Sudhahar , V. ; Kim , S.J. ; Chen , G.F. ; McKinney , R.D. ; Kojda , G. ; Fukai , T. ; Ushio-Fukai , M . Critical role of endothelial hydrogen peroxide in post-ischemic neovascularization . PLoS One 2013 , 8 , e57618 , doi: 10.1371/journal.pone.0057618 . OpenUrl CrossRef PubMed 9. ↵ Hecquet , C.M. ; Ahmmed , G.U. ; Vogel , S.M. ; Malik , A.B . Role of TRPM2 channel in mediating H2O2-induced Ca2+ entry and endothelial hyperpermeability . Circ Res 2008 , 102 , 347 – 355 , doi: 10.1161/circresaha.107.160176 . OpenUrl Abstract / FREE Full Text 10. ↵ Incalza , M.A. ; D’Oria , R. ; Natalicchio , A. ; Perrini , S. ; Laviola , L. ; Giorgino , F . Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases . Vascular Pharmacology 2018 , 100 , 1 – 19 , doi: 10.1016/j.vph.2017.05.005 . OpenUrl CrossRef PubMed 11. ↵ Lum , H. ; Roebuck , K.A . Oxidant stress and endothelial cell dysfunction . Am J Physiol Cell Physiol 2001 , 280 , C719 – 741 , doi: 10.1152/ajpcell.2001.280.4.C719 . OpenUrl CrossRef PubMed Web of Science 12. ↵ Takahashi , N. ; Kozai , D. ; Kobayashi , R. ; Ebert , M. ; Mori , Y . Roles of TRPM2 in oxidative stress . Cell Calcium 2011 , 50 , 279 – 287 , doi: 10.1016/j.ceca.2011.04.006 . OpenUrl CrossRef PubMed Web of Science 13. ↵ Yun , J. ; Rocic , P. ; Pung , Y.F. ; Belmadani , S. ; Carrao , A.C. ; Ohanyan , V. ; Chilian , W.M . Redox-dependent mechanisms in coronary collateral growth: the “redox window” hypothesis . Antioxid Redox Signal 2009 , 11 , 1961 – 1974 , doi: 10.1089/ars.2009.2476 . OpenUrl CrossRef PubMed 14. ↵ Troyanovsky , S.M . Adherens junction: the ensemble of specialized cadherin clusters . Trends Cell Biol 2023 , 33 , 374 – 387 , doi: 10.1016/j.tcb.2022.08.007 . OpenUrl CrossRef PubMed 15. ↵ Lum , H. ; Malik , A.B . Regulation of vascular endothelial barrier function . Am J Physiol 1994 , 267 , L223 – 241 , doi: 10.1152/ajplung.1994.267.3.L223 . OpenUrl CrossRef 16. ↵ Tatsumi , M. ; Kishi , T. ; Ishida , S. ; Kawana , H. ; Uwamizu , A. ; Ono , Y. ; Kawakami , K. ; Aoki , J. ; Inoue , A . Ectodomain shedding of EGFR ligands serves as an activation readout for TRP channels . PLoS One 2023 , 18 , e0280448 , doi: 10.1371/journal.pone.0280448 . OpenUrl CrossRef PubMed 17. ↵ Schulz , B. ; Pruessmeyer , J. ; Maretzky , T. ; Ludwig , A. ; Blobel , C.P. ; Saftig , P. ; Reiss , K . ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin . Circ Res 2008 , 102 , 1192 – 1201 , doi: 10.1161/circresaha.107.169805 . OpenUrl Abstract / FREE Full Text 18. ↵ Ding , R. ; Yin , Y.L. ; Jiang , L.H . Reactive Oxygen Species-Induced TRPM2-Mediated Ca(2+) Signalling in Endothelial Cells . Antioxidants (Basel ) 2021 , 10 , doi: 10.3390/antiox10050718 . OpenUrl CrossRef 19. ↵ Malko , P. ; Jiang , L.H . TRPM2 channel-mediated cell death: An important mechanism linking oxidative stress-inducing pathological factors to associated pathological conditions . Redox Biol 2020 , 37 , 101755 , doi: 10.1016/j.redox.2020.101755 . OpenUrl CrossRef PubMed 20. Jiang , L.H. ; Yang , W. ; Zou , J. ; Beech , D.J . TRPM2 channel properties, functions and therapeutic potentials . Expert Opin Ther Targets 2010 , 14 , 973 – 988 , doi: 10.1517/14728222.2010.510135 . OpenUrl CrossRef PubMed Web of Science 21. ↵ Tóth , B. ; Iordanov , I. ; Csanády , L . Selective profiling of N- and C-terminal nucleotide-binding sites in a TRPM2 channel . J Gen Physiol 2020 , 152 , doi: 10.1085/jgp.201912533 . OpenUrl CrossRef 22. ↵ Mittal , M. ; Urao , N. ; Hecquet , C.M. ; Zhang , M. ; Sudhahar , V. ; Gao , X.P. ; Komarova , Y. ; Ushio-Fukai , M. ; Malik , A.B . Novel role of reactive oxygen species-activated Trp melastatin channel-2 in mediating angiogenesis and postischemic neovascularization . Arterioscler Thromb Vasc Biol 2015 , 35 , 877 – 887 , doi: 10.1161/atvbaha.114.304802 . OpenUrl Abstract / FREE Full Text 23. ↵ Peralvarez-Marin , A. ; Donate-Macian , P. ; Gaudet , R . What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel? FEBS J 2013 , 280 , 5471 – 5487 , doi: 10.1111/febs.12302 . OpenUrl CrossRef PubMed 24. ↵ Fricke , T.C. ; Echtermeyer , F. ; Zielke , J. ; de la Roche , J. ; Filipovic , M.R. ; Claverol , S. ; Herzog , C. ; Tominaga , M. ; Pumroy , R.A. ; Moiseenkova-Bell , V.Y. , et al. Oxidation of methionine residues activates the high-threshold heat-sensitive ion channel TRPV2 . Proc Natl Acad Sci U S A 2019 , 116 , 24359 – 24365 , doi: 10.1073/pnas.1904332116 . OpenUrl Abstract / FREE Full Text 25. ↵ Oda , M. ; Fujiwara , Y. ; Ishizaki , Y. ; Shibasaki , K . Oxidation sensitizes TRPV2 to chemical and heat stimuli, but not mechanical stimulation . Biochem Biophys Rep 2021 , 28 , 101173 , doi: 10.1016/j.bbrep.2021.101173 . OpenUrl CrossRef PubMed 26. ↵ Schupp , J.C. ; Adams , T.S. ; Cosme , C. ; Raredon , M.S.B. ; Yuan , Y. ; Omote , N. ; Poli , S. ; Chioccioli , M. ; Rose , K.-A. ; Manning , E.P. , et al. Integrated Single-Cell Atlas of Endothelial Cells of the Human Lung . Circulation 2021 , 144 , 286 – 302 , doi: 10.1161/CIRCULATIONAHA.120.052318 . OpenUrl CrossRef 27. ↵ Luo , H. ; Rossi , E. ; Saubamea , B. ; Chasseigneaux , S. ; Cochois , V. ; Choublier , N. ; Smirnova , M. ; Glacial , F. ; Perriere , N. ; Bourdoulous , S. , et al. Cannabidiol Increases Proliferation, Migration, Tubulogenesis, and Integrity of Human Brain Endothelial Cells through TRPV2 Activation . Mol Pharm 2019 , 16 , 1312 – 1326 , doi: 10.1021/acs.molpharmaceut.8b01252 . OpenUrl CrossRef 28. ↵ Villalta , P.C. ; Townsley , M.I . Transient receptor potential channels and regulation of lung endothelial permeability . Pulm Circ 2013 , 3 , 802 – 815 , doi: 10.1086/674765 . OpenUrl CrossRef PubMed 29. ↵ Zheng , X. ; Zhang , W. ; Hu , X . Different concentrations of lipopolysaccharide regulate barrier function through the PI3K/Akt signalling pathway in human pulmonary microvascular endothelial cells . Sci Rep 2018 , 8 , 9963 , doi: 10.1038/s41598-018-28089-3 . OpenUrl CrossRef PubMed 30. ↵ Ludwig , A. ; Hundhausen , C. ; Lambert , M.H. ; Broadway , N. ; Andrews , R.C. ; Bickett , D.M. ; Leesnitzer , M.A. ; Becherer , J.D . Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules . Comb Chem High Throughput Screen 2005 , 8 , 161 – 171 , doi: 10.2174/1386207053258488 . OpenUrl CrossRef PubMed Web of Science 31. ↵ Conde , J. ; Pumroy , R.A. ; Baker , C. ; Rodrigues , T. ; Guerreiro , A. ; Sousa , B.B. ; Marques , M.C. ; de Almeida , B.P. ; Lee , S. ; Leites , E.P. , et al. Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression . ACS Central Science 2021 , 7 , 868 – 881 , doi: 10.1021/acscentsci.1c00070 . OpenUrl CrossRef PubMed 32. ↵ Hill , K. ; McNulty , S. ; Randall , A.D . Inhibition of TRPM2 channels by the antifungal agents clotrimazole and econazole . Naunyn Schmiedebergs Arch Pharmacol 2004 , 370 , 227 – 237 , doi: 10.1007/s00210-004-0981-y . OpenUrl CrossRef PubMed Web of Science 33. ↵ Cheung , M. ; Bao , W. ; Behm , D.J. ; Brooks , C.A. ; Bury , M.J. ; Dowdell , S.E. ; Eidam , H.S. ; Fox , R.M. ; Goodman , K.B. ; Holt , D.A. , et al. Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4 . ACS Med Chem Lett 2017 , 8 , 549 – 554 , doi: 10.1021/acsmedchemlett.7b00094 . OpenUrl CrossRef PubMed 34. ↵ Finkel , T . Signal transduction by reactive oxygen species . J Cell Biol 2011 , 194 , 7 – 15 , doi: 10.1083/jcb.201102095 . OpenUrl Abstract / FREE Full Text 35. ↵ Linder , S. ; Aepfelbacher , M . Podosomes: adhesion hot-spots of invasive cells . Trends Cell Biol 2003 , 13 , 376 – 385 , doi: 10.1016/s0962-8924(03)00128-4 . OpenUrl CrossRef PubMed Web of Science 36. ↵ Nagasawa , M. ; Nakagawa , Y. ; Tanaka , S. ; Kojima , I . Chemotactic peptide fMetLeuPhe induces translocation of the TRPV2 channel in macrophages . J Cell Physiol 2007 , 210 , 692 – 702 , doi: 10.1002/jcp.20883 . OpenUrl CrossRef PubMed Web of Science 37. ↵ Reiss , K. ; Ludwig , A. ; Saftig , P . Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion . Pharmacol Ther 2006 , 111 , 985 – 1006 , doi: 10.1016/j.pharmthera.2006.02.009 . OpenUrl CrossRef PubMed Web of Science 38. ↵ Mittal , M. ; Nepal , S. ; Tsukasaki , Y. ; Hecquet , C.M. ; Soni , D. ; Rehman , J. ; Tiruppathi , C. ; Malik , A.B . Neutrophil Activation of Endothelial Cell-Expressed TRPM2 Mediates Transendothelial Neutrophil Migration and Vascular Injury . Circ Res 2017 , 121 , 1081 – 1091 , doi: 10.1161/circresaha.117.311747 . OpenUrl Abstract / FREE Full Text 39. ↵ Kevil , C.G. ; Ohno , N. ; Gute , D.C. ; Okayama , N. ; Robinson , S.A. ; Chaney , E. ; Alexander , J.S . Role of cadherin internalization in hydrogen peroxide-mediated endothelial permeability . Free Radic Biol Med 1998 , 24 , 1015 – 1022 , doi: 10.1016/s0891-5849(97)00433-4 . OpenUrl CrossRef PubMed Web of Science 40. ↵ Vincent , P.A. ; Xiao , K. ; Buckley , K.M. ; Kowalczyk , A.P . VE-cadherin: adhesion at arm’s length . Am J Physiol Cell Physiol 2004 , 286 , C987 – 997 , doi: 10.1152/ajpcell.00522.2003 . OpenUrl CrossRef PubMed Web of Science 41. ↵ Bazzoni , G. ; Dejana , E . Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis . Physiol Rev 2004 , 84 , 869 – 901 , doi: 10.1152/physrev.00035.2003 . OpenUrl CrossRef PubMed Web of Science 42. ↵ Grazia Lampugnani , M. ; Zanetti , A. ; Corada , M. ; Takahashi , T. ; Balconi , G. ; Breviario , F. ; Orsenigo , F. ; Cattelino , A. ; Kemler , R. ; Daniel , T.O. , et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148 . J Cell Biol 2003 , 161 , 793 – 804 , doi: 10.1083/jcb.200209019 . OpenUrl Abstract / FREE Full Text 43. ↵ Navarro , P. ; Ruco , L. ; Dejana , E . Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization . J Cell Biol 1998 , 140 , 1475 – 1484 , doi: 10.1083/jcb.140.6.1475 . OpenUrl Abstract / FREE Full Text 44. ↵ Kruse , K. ; Lee , Q.S. ; Sun , Y. ; Klomp , J. ; Yang , X. ; Huang , F. ; Sun , M.Y. ; Zhao , S. ; Hong , Z. ; Vogel , S.M. , et al. N-cadherin signaling via Trio assembles adherens junctions to restrict endothelial permeability . J Cell Biol 2019 , 218 , 299 – 316 , doi: 10.1083/jcb.201802076 . OpenUrl Abstract / FREE Full Text 45. ↵ Liu , X. ; Zweier , J.L . A real-time electrochemical technique for measurement of cellular hydrogen peroxide generation and consumption: evaluation in human polymorphonuclear leukocytes . Free Radical Biology and Medicine 2001 , 31 , 894 – 901 , doi: 10.1016/S0891-5849(01)00665-7 . OpenUrl CrossRef PubMed Web of Science View the discussion thread. Back to top Previous Next Posted February 16, 2025. Download PDF Email Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following TRPV2 and TRPM2 channels facilitate pulmonary endothelial barrier recovery after ROS-induced permeability Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share TRPV2 and TRPM2 channels facilitate pulmonary endothelial barrier recovery after ROS-induced permeability Lena Schaller , Thomas Gudermann , Alexander Dietrich bioRxiv 2025.02.13.638083; doi: https://doi.org/10.1101/2025.02.13.638083 Share This Article: Copy Citation Tools TRPV2 and TRPM2 channels facilitate pulmonary endothelial barrier recovery after ROS-induced permeability Lena Schaller , Thomas Gudermann , Alexander Dietrich bioRxiv 2025.02.13.638083; doi: https://doi.org/10.1101/2025.02.13.638083 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Cell Biology Subject Areas All Articles Animal Behavior and Cognition (7622) Biochemistry (17648) Bioengineering (13871) Bioinformatics (41880) Biophysics (21423) Cancer Biology (18558) Cell Biology (25460) Clinical Trials (138) Developmental Biology (13364) Ecology (19866) Epidemiology (2067) Evolutionary Biology (24290) Genetics (15589) Genomics (22475) Immunology (17711) Microbiology (40327) Molecular Biology (17145) Neuroscience (88473) Paleontology (666) Pathology (2827) Pharmacology and Toxicology (4816) Physiology (7635) Plant Biology (15114) Scientific Communication and Education (2044) Synthetic Biology (4286) Systems Biology (9815) Zoology (2268)